Objectives: The global results of various series of heart transplantat
ion (HT) are essential to assess the life expectancy provided by this
technique. Due to the increasing graft shortage, it appears essential
to very strictly candidates for HT. Methods: From March 8, 1989 to Dec
ember 7, 1994, 75 orthotopic Hts were performed in 62 men and 12 women
(1 case of retransplantation). The mean age was 47.46 +/- 15.02 years
(range: 2.5-66 years). Four patients were younger than 10 years and 2
2 were older than 60 years. Our series included more cases of ischaemi
c heart disease (36) than dilated cardiomyopathies (33), with a histor
y of cardiac surgery in almost one quarter (20) of patients with ischa
emic heart disease. Results: The immediate postoperative survival rate
was 94.7% with 3 deaths attributable to refractory pulmonary hyperten
sion associated with graft failure and one death related to postoperat
ive tamponade. Five other patients died during the following 3 months,
increasing the mean global survival to 88%. After a mean follow-up of
2.1 years (maximum 5.8 years), the actuarial 5-year survival rate was
56.8%. Elevan patients died between 4 and 38 months (mean: 18.2 month
s). Two deaths were due to cancers, 4 were due to septicaemia, another
4 were due to rejection and finally 1 was due to meningeal haemorrhag
e. The frequency (19) of reoperations for clot removal was due to the
large number of patients with a history of previous heart surgery (20)
. Conclusion: Strict recipient selection, possibly based on I-123-MIBG
scintigraphy, the use of pulsatile circulatory assistance system, imp
roved CMV, morphometry and donor-recipient age matching, should optimi
ze the results of a technique, whose efficacy is confirmed in this ser
ies.